Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination

NCT04247074 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

413

Enrollment

INDUSTRY

Sponsor class

Conditions

Glabellar Frown Lines (GL)
Lateral Canthal Lines (LCL)

Interventions

BIOLOGICAL: botulinum toxin neuromodulator
BIOLOGICAL: Placebo

Sponsor

Galderma R&D